What amorolfine 5% nail lacquer treats
Amorolfine 5% nail lacquer is a topical antifungal medicine labelled for fungal nail infections. Amorolfine is the active ingredient; individual products may be sold under different brand names. The cited UK Zentiva product contains 50 mg/ml amorolfine, equivalent to 55.74 mg/ml amorolfine hydrochloride. Its prescription-only status applies to that specific product and should not automatically be applied to every amorolfine brand or pack in the UK.
Not every thick, brittle, ridged or discoloured nail has a fungal infection. Nail appearance alone cannot reliably establish the diagnosis, and treating the wrong cause may delay appropriate care. Fungal infection is more likely to be considered when the nail changes fit a recognised pattern, but confirmation and treatment suitability may be particularly important when the appearance is unusual or the diagnosis is uncertain.
Check the leaflet supplied with the exact product you have. Instructions, authorisation, accessories and supply arrangements can differ between formulations and brands. The application frequency and other directions for the cited UK product should not be assumed to apply to every amorolfine lacquer.
How amorolfine works in the nail
Amorolfine belongs to the morpholine group of antifungal medicines. Applied to the nail, the lacquer forms a medicated film that allows the active ingredient to pass through the nail plate toward the affected area.
Inside susceptible fungi, amorolfine inhibits enzymes involved in ergosterol production. Ergosterol is an important component of the fungal cell membrane. Disrupting its production changes the membrane's composition and interferes with the fungus's ability to maintain its cellular structure.
This mechanism explains why regular application is needed while the affected nail grows out. The lacquer does not make existing discoloration disappear immediately, and a visible change does not by itself confirm that the infection has cleared. The result also depends on factors such as the type and extent of nail involvement and whether the diagnosis is correct.
When topical amorolfine may be suitable
Topical amorolfine may be considered when fungal nail infection is confirmed and the disease is limited. Consensus guidance places topical treatment mainly in situations such as distal disease without involvement of the nail matrix or dermatophytoma, and in classical white superficial onychomycosis. The matrix is the nail-producing area beneath the skin at the base of the nail. If it is involved, lacquer may be less suitable as the only treatment.
Treatment selection can depend on the suspected pathogen, the clinical subtype, how many nails are affected, whether fingernails or toenails are involved, nail thickness and the presence of fungal infection at other sites. More extensive disease or disease close to the matrix may require a different clinical approach.
A nail that looks abnormal should not automatically be treated with amorolfine. Confirming onychomycosis mycologically before treatment can help distinguish fungal infection from other causes of nail change. This is especially relevant when the appearance is atypical, several possible causes exist or the likely extent of infection is unclear.
Fingernails and toenails also need different expectations because the cited UK product leaflet gives different usual treatment durations: about six months for fingernails and nine to twelve months for toenails. These are typical timeframes for the product, not guaranteed cure dates.
How to apply amorolfine nail lacquer correctly
For the cited UK product, follow the exact instructions supplied with the pack and any directions from the prescriber. The leaflet directs application to affected fingernails or toenails once or twice weekly, exactly as instructed for that product.
The application sequence is:
- Before the first application, file the affected parts and surface of the nail.
- Clean the nail.
- Apply the lacquer evenly over the whole affected nail.
- Allow it to dry for about three minutes.
- Clean the reusable applicator after use.
Before later applications, remove the old lacquer. Remove any cosmetic nail varnish as well, then file the nail again if necessary before applying the next coat. Files used on infected nails should not be used on healthy nails or shared with another person, because this could spread infected nail material.
The cited product does not permit artificial nails during treatment. Cosmetic nail varnish is permitted under its instructions, but only after waiting at least ten minutes after applying amorolfine. The cosmetic varnish must be removed before the next amorolfine application. This permission is product-specific, so check the leaflet for any other formulation.
Results, treatment duration and signs of progress
Amorolfine treatment is intended to continue until the infection has cleared and healthy nail has grown back. Under the cited UK product instructions, this usually takes about six months for fingernails and nine to twelve months for toenails. Toenails generally require a longer period because the nail must grow out over a longer distance. These usual durations are not promises that every infection will clear within that time.
Early improvement may appear as a clearer section of nail growing from the base, while the older discoloured or damaged portion remains visible and gradually moves toward the tip. A better-looking nail is not the same as confirmed mycological cure, and persistent abnormality does not always show whether living fungus remains. Professional review may be needed when the response is unclear.
In one multicentre randomized study, people used amorolfine 5% once or twice weekly for six months and were assessed three months after treatment. Negative mycology was reported in 71% with once-weekly use and 76% with twice-weekly use. Combined clinical and mycological cure was reported in 46% and 51.8%, respectively. These findings describe that study's participants, regimen and assessment timing; they are not personal predictions or guaranteed outcomes.
Results from combination treatment should not be used to predict what amorolfine alone will achieve.
Side effects, precautions and product handling
Labelled local or nail-related effects for the cited product include rare nail damage, nail discoloration, and fragile or brittle nails. Very rare skin burning has also been reported. Redness, itching, hives, blisters and allergic skin reactions are listed with an unknown frequency.
Stop applying the product, remove it and seek urgent medical help if difficulty breathing, swelling of the face, lips, tongue or throat, or a severe rash develops. The leaflet says not to reapply the product after such a reaction.
Keep the lacquer on the nail rather than the surrounding skin, and do not allow it into the eyes, ears or mucous membranes. Do not inhale it. After eye or ear exposure, rinse immediately with water and contact a doctor. Contact a doctor after accidental swallowing. Because the product contains ethanol, keep it away from flames, lit cigarettes and certain heat-producing devices.
The cited product should not be used in children or during pregnancy or breastfeeding. Its leaflet reports no known interactions with other medicines. Store it below 30°C, away from heat, with the bottle tightly closed and out of children's sight and reach. These instructions apply to the cited UK product; other formulations may have different product information.
When to seek medical or pharmacy advice
Seek medical or pharmacy advice when it is unclear whether the nail changes are caused by fungus. Professional assessment is also appropriate when disease appears extensive, affects several nails, is close to the nail matrix or does not seem suitable for topical treatment alone. Nail appearance should not be used to make a confident diagnosis or treatment decision without considering other possible causes.
Arrange a routine review if there is no convincing progress, the nail becomes worse, the problem returns or you are unsure whether to continue. There is no single treatment-failure deadline that applies to everyone. Nail growth is slow, and the cited product leaflet expects treatment to continue until infection has cleared and healthy nail has grown back. Worsening or uncertainty should not simply be ignored.
Urgent help is needed for difficulty breathing, swelling of the face, lips, tongue or throat, or a severe rash. In that situation, stop applying the lacquer, remove it and do not use it again unless a healthcare professional specifically advises otherwise.
A pharmacist or prescriber can also check whether the application method, repeat-use frequency and product-specific instructions are being followed correctly. If your pack differs from the cited UK product, use its own leaflet rather than relying on a general amorolfine schedule.
Amorolfine compared with other treatment approaches
The choice between a topical lacquer, an oral antifungal approach or another treatment depends on the suspected pathogen, the pattern and extent of disease, nail thickness, the number and location of affected nails, matrix involvement and individual patient factors. A topical lacquer is not automatically appropriate for every confirmed infection, and a more extensive infection may need a different clinical assessment.
Amorolfine 5% and ciclopirox 8% are both topical antifungal nail lacquers, but they contain different active ingredients, have different mechanisms and use different application regimens. Studies of the two products may also involve different populations, schedules and definitions of cure. For these reasons, comparative results cannot simply be treated as a direct ranking that proves one lacquer is universally better.
Combination treatment is another distinct approach. A small randomized study in adults with confirmed fingernail onychomycosis examined weekly oral fluconazole together with weekly amorolfine and compared it with fluconazole plus a dummy lacquer. Its findings apply to that combination, population and study design. They do not establish the same results for amorolfine monotherapy, toenail infection or a general recommendation to use oral fluconazole.
Oral treatment choices, including their suitability, safety considerations and interactions, require individual clinical assessment. They should not be inferred from evidence about a lacquer used alone or in combination.